Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PFAS in the circular economy: An unintended consequence of recycling and wastewater reuse?

Integrated environmental assessment and management·2026
Same author

A review on assessment of advances in polymers and their hybrid nanosystem for leukaemia theranostics applications.

Biomedical materials (Bristol, England)·2026
Same author

Effects of ketone bodies supplementation in patients with heart failure: A systematic review and meta-analysis.

World journal of critical care medicine·2026
Same author

A wearable biosensing platform for continuous monitoring of inflammatory and metabolic biomarkers for real-time health tracking and personalized care.

Bioengineering & translational medicine·2026
Same author

Environmental applications of silver nanoparticles: state-of-the-art review and emerging trends.

Beilstein journal of nanotechnology·2026
Same author

Outcomes and predictive factors in pediatric drowning: a systematic review and meta-analysis of prehospital predictors.

International journal of injury control and safety promotion·2026

Related Experiment Video

Updated: Mar 16, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

832

Machine Learning Algorithm for Nanomedicine: AI Curated Nanocarriers for Cancer Treatment.

Akash Kumar1, Sumaiya Qasim1, Ashwani Sharma2

  • 1Department of Pharmaceutical Analysis, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, India.

Current Pharmaceutical Design
|March 15, 2026
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) optimizes nanoparticle (NP) design for targeted cancer drug delivery systems (DDSs), improving treatment efficacy. This AI-driven approach enhances drug bioavailability and tumor specificity, paving the way for personalized cancer therapies.

Keywords:
Cancer therapyartificial intelligencedrug delivery systemmachine learningnanoparticlesprecision medicine.

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.4K

Related Experiment Videos

Last Updated: Mar 16, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

832
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.2K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

8.4K

Area of Science:

  • Oncology
  • Nanotechnology
  • Artificial Intelligence

Background:

  • Cancer's genetic variability complicates effective therapy development.
  • Nanoparticle (NP) drug delivery systems (DDSs) offer potential for targeted cancer treatment.
  • Integrating AI can overcome challenges in NP design and drug delivery.

Purpose of the Study:

  • To review the integration of AI-driven methodologies in nanoparticle design for cancer therapy.
  • To elucidate how AI optimizes drug delivery systems (DDSs) for enhanced cancer treatment.
  • To highlight AI's role in developing next-generation smart therapeutics.

Main Methods:

  • Utilizing AI predictive analytics for rational nanocarrier design.
  • Employing machine learning (ML) models to accelerate NP fabrication and simulate tumor dynamics.
  • Leveraging AI platforms (e.g., EVOnano) to simulate in silico tumor microenvironments.

Main Results:

  • AI enhances nanocarrier design, improving drug bioavailability, pharmacokinetics, and tumor penetration.
  • ML models accelerate NP fabrication and enable real-time simulation of drug release kinetics.
  • AI-assisted nanomedicine demonstrates potential for enhanced tumor specificity and reduced systemic toxicity.

Conclusions:

  • AI-assisted nanomedicine represents a paradigm shift in cancer treatment.
  • This approach facilitates the development of patient-tailored, data-driven precision therapeutics.
  • Interdisciplinary advances are needed to address challenges like scalability and biological heterogeneity.